What is the global market size of Pediatric Home Healthcare Market?

Global Pediatric Home Healthcare Market size was valued at USD 286.35 billion in 2021 and is poised to grow from USD 314.8 billion in 2022 to USD 514.5 billion by 2030, growing at a CAGR of 7.9% in the forecast period (2023-2030).

Who are the key vendors in the Global Pediatric Home Healthcare Market?

In the home healthcare market, the pediatric care service is a booming segment that presents operators with tremendous opportunities to grow their businesses. The greatest income-generating specialty for BAYADA Home Health Care, one of the market's key participants, and the source of nearly one-third of its revenue is pediatric nursing services. 'Aveanna Healthcare', 'Bayada Home Health Care', 'BrightStar Care', 'Interim HealthCare', 'Maxim Healthcare Services', 'Pediatric Home Service', 'Pediatria Healthcare for Kids', 'Advanced Home Care', 'Angels of Care Pediatric Home Health', 'Epic Health Services', 'HealthBridge Children's Hospital Home Care', 'Intellichoice Home Care', 'MedCare Pediatric Group', 'Continuum Pediatric Nursing Services', 'Pediatric Home Healthcare, LLC', 'PSA Healthcare', 'Tender Nursing Care', 'VNA Health Group', 'All Metro Health Care', 'KidsCare Home Health'

Pediatric Home Healthcare Market Size

Pediatric Home Healthcare Market Insights

Global Pediatric Home Healthcare Market size was valued at USD 37.2 billion in 2023 and is poised to grow from USD 40.14 billion in 2024 to USD 73.75 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

Pediatric pollution worldwide is becoming more common with chronic disorders such as cerebral palsy, congenital heart problems, cystic fibrosis, muscular dystrophy, epilepsy, and cancer. This has opened up prospects for important players to invest in the market. Around 5.6 million children in the United States required at least 5 hours of in-home medical care, according to NS–CSHCN. An estimated 1.5 billion hours are spent annually by parents caring for their children, costing each household $3,200.

Infants with complicated cardiac, neurological, and respiratory issues have had fewer hospital visits because of life-sustaining pediatric home healthcare services provided in a cost setting. One in five children between the ages of 5 and 19 need special medical care, According to the National Survey of Children with Special Healthcare Needs. Children with Special Healthcare Needs (CSHCN) are more common, but having access to pediatric home healthcare services enhances their quality of life and significantly lowers their medical costs.

Additionally, the need for in-home pediatric care services has grown as a result of improved medical procedures that have extended the life expectancy of preterm babies. Premature babies that weigh less than 1 pound typically have a number of chronic illnesses and need particular care from an early age.

Additionally, with the aid of pediatric nursing care at home, infants with complex disorders can now be discharged from neonatal critical care units. These technologies and tools include ventilators, CPAP machines, gastric tubes, nebulizers, and apnea monitors.

US Pediatric Home Healthcare Market is poised to grow at a sustainable CAGR for the next forecast year.

FAQs

In the home healthcare market, the pediatric care service is a booming segment that presents operators with tremendous opportunities to grow their businesses. The greatest income-generating specialty for BAYADA Home Health Care, one of the market's key participants, and the source of nearly one-third of its revenue is pediatric nursing services. 'AstraZeneca plc (United Kingdom) ', 'Pfizer Inc. (United States) ', 'Sanofi S.A. (France) ', 'Boehringer Ingelheim GmbH (Germany) ', 'Eisai Co., Ltd. (Japan) ', 'Gilead Sciences, Inc. (United States) ', 'GlaxoSmithKline plc (United Kingdom) ', 'Merck & Co., Inc. (United States) ', 'Novartis AG (Switzerland) ', 'Johnson & Johnson (United States) ', 'Eli Lilly and Company (United States) ', 'Bristol-Myers Squibb Company (United States) ', 'Amedisys Inc. (United States) ', 'Maxim Healthcare Services (United States) ', 'Cardinal Health, Inc. (United States) ', 'B. Braun Melsungen AG (Germany) ', 'Team Select Home Care (United States) ', 'Portea Medical (India)'

Pediatric home health care essentially consists of medical facilities that offer children medical services to enhance their health and support their entire development. For support, family members are also present in the medical facility.

Due to the ongoing COVID-19 pandemic, there will likely be an increase in the need for home care services in the near future. These services are both affordable and safe substitutes for healthcare services external alternatives, such as hospitals. The threat posed by informal care and other healthcare facilities is limited, mostly because to their high prices. Hence, the market's threat from replacement products throughout the forecast period, is anticipated to be moderate.

Due to rising awareness of pediatric home-based medical services, North America dominated the global pediatric home healthcare market and held the greatest revenue share of close to 35.0 %. Nearly 500,000 newborns and adolescents with exceptional medical requirements require various medical and therapeutic assistance in their homes, according to a report on children with complicated medical disorders in the U.S. Long-term hospital stays can considerably raise medical costs, whereas pediatric home-based therapies are more affordable and enhance patient care. As a result, a wide variety of suppliers in the U.S. are providing a range of services to satisfy this expanding need.